Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ID Remedies is a small private pharmaceutical drug development consulting company rather than a therapeutics developer with an internal clinical pipeline. Publicly available executive biographies describe the company as providing scientific, medical, clinical development, regulatory, and business development consulting services to biopharmaceutical companies. The business appears to have been led by Margaret Wasilewski, M.D., who has been repeatedly identified as President of ID Remedies. Historical and more recent third-party records indicate the legal entity is ID Remedies LLC and that it has remained active as a registered company. Based on available evidence, ID Remedies operates as a healthcare-focused consulting firm supporting drug development programs across multiple therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ID Remedies.